Nkarta Inc (NKTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $85.23M
Last updated: Nov 17, 2026 at 11:05 AM ET
Nkarta Inc (NKTX) Stock Forecast
Analysts expect Nkarta (NKTX) to earn -$1.83 per share in the fiscal year ending Dec 31, 2026. Of 7 analysts, 7 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$1.51.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 1.86, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 14.3% |
| Buy | 6 | 85.7% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 7
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$1.83
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$1.51
- EPS consensus
- Next report
- Mar 23, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$1.83 | -$1.84 to -$1.81 | 2 |
| Dec 31, 2027 | -$1.51 | -$1.72 to -$1.27 | 3 |
Quarterly Estimates
The EPS consensus rises from -$0.44 for the quarter ending Dec 31, 2026 to -$0.42 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.44 | -$0.50 to -$0.37 | 8 |
| Mar 31, 2027 | -$0.42 | -$0.42 to -$0.42 | 1 |
Estimate Revisions
No EPS estimate for the 3 periods below was revised in the last 30 days.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 0 |
| Fiscal year ending Dec 31, 2027 | 0 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$1.48.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$1.83 | -$1.71 | -$1.71 | -$1.71 | -$1.48 | N/A |
| Fiscal year ending Dec 31, 2027 | -$1.51 | -$1.75 | -$1.75 | -$1.75 | -$1.65 | N/A |
| Quarter ending Mar 31, 2027 | -$0.42 | -$0.36 | -$0.36 | -$0.36 | -$0.37 | N/A |
Frequently Asked Questions About NKTX
What is the NKTX stock forecast?
Consensus analyst estimates put Nkarta's EPS at -$1.83 for the fiscal year ending Dec 31, 2026. The consensus rating from 7 analysts is Buy.
How do analysts rate NKTX stock?
Of 7 analysts covering Nkarta, 1 rates it Strong Buy, 6 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from NKTX next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.83, with estimates from -$1.84 to -$1.81 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.51, with estimates from -$1.72 to -$1.27 from 3 analysts.
How many analysts cover NKTX?
7 analysts rate Nkarta stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
NKTX pages: Overview, Earnings, Forecast, Financials, Competitors